annual shareholders equity:
-$109.99M+$51.06M(+31.70%)Summary
- As of today (May 29, 2025), ASND annual stockholders equity is -$109.99 million, with the most recent change of +$51.06 million (+31.70%) on December 31, 2024.
- During the last 3 years, ASND annual shareholders equity has fallen by -$1.11 billion (-110.99%).
- ASND annual shareholders equity is now -110.66% below its all-time high of $1.03 billion, reached on December 31, 2020.
Performance
ASND Shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly shareholders equity:
-$205.43M-$95.44M(-86.77%)Summary
- As of today (May 29, 2025), ASND quarterly stockholders equity is -$205.43 million, with the most recent change of -$95.44 million (-86.77%) on March 31, 2025.
- Over the past year, ASND quarterly shareholders equity has increased by +$51.78 million (+20.13%).
- ASND quarterly shareholders equity is now -117.83% below its all-time high of $1.15 billion, reached on September 30, 2021.
Performance
ASND quarterly shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Shareholders equity Formula
Shareholders Equity = Total Assets − Total Liabilities
ASND Shareholders equity Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +31.7% | +20.1% |
3 y3 years | -111.0% | -127.4% |
5 y5 years | -116.4% | -133.9% |
ASND Shareholders equity Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -111.0% | +31.7% | -127.4% | +40.3% |
5 y | 5-year | -110.7% | +31.7% | -117.8% | +40.3% |
alltime | all time | -110.7% | +31.7% | -117.8% | +40.3% |
ASND Shareholders equity History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | -$205.43M(+86.8%) |
Dec 2024 | -$109.99M(-31.7%) | -$109.99M(+1.2%) |
Sep 2024 | - | -$108.70M(-68.4%) |
Jun 2024 | - | -$344.22M(+33.8%) |
Mar 2024 | - | -$257.21M(+59.7%) |
Dec 2023 | -$161.05M(-157.0%) | -$161.05M(+107.2%) |
Sep 2023 | - | -$77.73M(-210.3%) |
Jun 2023 | - | $70.47M(-61.4%) |
Mar 2023 | - | $182.32M(-35.4%) |
Dec 2022 | $282.41M(-71.8%) | $282.41M(-36.4%) |
Sep 2022 | - | $443.83M(-30.1%) |
Jun 2022 | - | $634.95M(-15.4%) |
Mar 2022 | - | $750.94M(-24.9%) |
Dec 2021 | $1.00B(-3.0%) | $1.00B(-13.2%) |
Sep 2021 | - | $1.15B(+40.9%) |
Jun 2021 | - | $818.13M(-13.1%) |
Mar 2021 | - | $941.14M(-8.8%) |
Dec 2020 | $1.03B(+54.2%) | $1.03B(-7.7%) |
Sep 2020 | - | $1.12B(+108.2%) |
Jun 2020 | - | $536.63M(-11.3%) |
Mar 2020 | - | $605.33M(-9.5%) |
Dec 2019 | $668.87M | $668.87M(-7.5%) |
Sep 2019 | - | $723.12M(-5.8%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2019 | - | $767.56M(-4.6%) |
Mar 2019 | - | $804.81M(+151.2%) |
Dec 2018 | $320.35M(+42.6%) | $320.35M(-9.4%) |
Sep 2018 | - | $353.49M(-8.0%) |
Jun 2018 | - | $384.12M(-10.3%) |
Mar 2018 | - | $428.33M(+90.7%) |
Dec 2017 | $224.60M(+20.3%) | $224.60M(-5.7%) |
Sep 2017 | - | $238.15M(+64.6%) |
Jun 2017 | - | $144.67M(-12.6%) |
Mar 2017 | - | $165.45M(-11.4%) |
Dec 2016 | $186.71M(+41.9%) | $186.71M(+123.7%) |
Sep 2016 | - | $83.47M(-17.5%) |
Jun 2016 | - | $101.12M(-12.4%) |
Mar 2016 | - | $115.50M(-12.2%) |
Dec 2015 | $131.56M(+136.2%) | $131.56M(-11.2%) |
Sep 2015 | - | $148.21M(-2.6%) |
Jun 2015 | - | $152.23M(-5.8%) |
Mar 2015 | - | $161.56M(+190.0%) |
Dec 2014 | $55.71M(+540.2%) | $55.71M(+1656.7%) |
Sep 2014 | - | $3.17M(-63.6%) |
Dec 2013 | $8.70M(+322.8%) | $8.70M |
Dec 2012 | $2.06M(+581.8%) | - |
Dec 2011 | $301.80K | - |
FAQ
- What is Ascendis Pharma A/S annual stockholders equity?
- What is the all time high annual shareholders equity for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S annual shareholders equity year-on-year change?
- What is Ascendis Pharma A/S quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S quarterly shareholders equity year-on-year change?
What is Ascendis Pharma A/S annual stockholders equity?
The current annual shareholders equity of ASND is -$109.99M
What is the all time high annual shareholders equity for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high annual stockholders equity is $1.03B
What is Ascendis Pharma A/S annual shareholders equity year-on-year change?
Over the past year, ASND annual stockholders equity has changed by +$51.06M (+31.70%)
What is Ascendis Pharma A/S quarterly stockholders equity?
The current quarterly shareholders equity of ASND is -$205.43M
What is the all time high quarterly shareholders equity for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high quarterly stockholders equity is $1.15B
What is Ascendis Pharma A/S quarterly shareholders equity year-on-year change?
Over the past year, ASND quarterly stockholders equity has changed by +$51.78M (+20.13%)